Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial.

Layland J, Oldroyd KG, Curzen N, Sood A, Balachandran K, Das R, Junejo S, Ahmed N, Lee MM, Shaukat A, O'Donnell A, Nam J, Briggs A, Henderson R, McConnachie A, Berry C; FAMOUS–NSTEMI investigators.

Eur Heart J. 2015 Jan 7;36(2):100-11. doi: 10.1093/eurheartj/ehu338. Epub 2014 Sep 1.

2.

A single center multioperator initial experience of 4,195 patients at a primary radial intervention program in a tertiary level center.

Gokhroo RK, Kaushik SK, Padmanabhan D, Bisht D, Gupta S.

Indian Heart J. 2014 Mar-Apr;66(2):169-75. doi: 10.1016/j.ihj.2013.10.002. Epub 2013 Nov 5.

3.

Risks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic Review.

Nascimento BR, de Sousa MR, Demarqui FN, Ribeiro AL.

ISRN Cardiol. 2014 Feb 6;2014:416253. doi: 10.1155/2014/416253. eCollection 2014. Review.

4.

Fractional flow reserve versus angiography in guiding management to optimize outcomes in non-ST-elevation myocardial infarction (FAMOUS-NSTEMI): rationale and design of a randomized controlled clinical trial.

Berry C, Layland J, Sood A, Curzen NP, Balachandran KP, Das R, Junejo S, Henderson RA, Briggs AH, Ford I, Oldroyd KG.

Am Heart J. 2013 Oct;166(4):662-668.e3. doi: 10.1016/j.ahj.2013.07.011. Epub 2013 Aug 27.

6.

Change in enrollment patterns, patient selection, and clinical outcomes with the availability of drug-eluting stents in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.

Shah B, Srinivas VS, Lu J, Brooks MM, Bates ER, Nedeljkovic ZS, Escobedo J, Das GS, Lopez JJ, Feit F.

Am Heart J. 2013 Sep;166(3):519-26. doi: 10.1016/j.ahj.2013.05.017. Epub 2013 Aug 6.

7.

Temporal trends in gastrointestinal bleeding associated with percutaneous coronary intervention: analysis of the 1998-2006 Nationwide Inpatient Sample (NIS) database.

Shivaraju A, Patel V, Fonarow GC, Xie H, Shroff AR, Vidovich MI.

Am Heart J. 2011 Dec;162(6):1062-1068.e5. doi: 10.1016/j.ahj.2011.09.009. Epub 2011 Nov 8.

8.

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium.

Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW.

Eur Heart J. 2011 Jan;32(2):205-17. doi: 10.1093/eurheartj/ehq406. Epub 2011 Jan 6.

9.

Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapy.

Parodi G, De Luca G, Moschi G, Bellandi B, Valenti R, Migliorini A, Carrabba N, Antoniucci D.

J Thromb Thrombolysis. 2010 Nov;30(4):446-51. doi: 10.1007/s11239-010-0481-5.

10.

Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial.

Mehran R, Pocock SJ, Stone GW, Clayton TC, Dangas GD, Feit F, Manoukian SV, Nikolsky E, Lansky AJ, Kirtane A, White HD, Colombo A, Ware JH, Moses JW, Ohman EM.

Eur Heart J. 2009 Jun;30(12):1457-66. doi: 10.1093/eurheartj/ehp110. Epub 2009 Apr 7.

11.

Prothrombotic markers and early spontaneous recanalization in ST-segment elevation myocardial infarction.

Huisse MG, Lanoy E, Tcheche D, Feldman LJ, Bezeaud A, Anglès-Cano E, Mary-Krause M, de Prost D, Guillin MC, Steg PG.

Thromb Haemost. 2007 Aug;98(2):420-6.

13.

Enoxaparin injection for the treatment of high-risk patients with non-ST elevation acute coronary syndrome.

Schmidt-Lucke C, Schultheiss HP.

Vasc Health Risk Manag. 2007;3(2):221-8. Review.

14.

Bivalirudin in percutaneous coronary intervention.

Lehman SJ, Chew DP.

Vasc Health Risk Manag. 2006;2(4):357-63. Review.

15.

Non ST segment elevation acute coronary syndromes: A simplified risk-orientated algorithm.

Fitchett DH, Borgundvaag B, Cantor W, Cohen E, Dhingra S, Fremes S, Gupta M, Heffernan M, Kertland H, Husain M, Langer A, Letovsky E, Goodman SG; Renewal of Non STE ACS Algorism Group.

Can J Cardiol. 2006 Jun;22(8):663-77. Review.

16.

Darwin and the survival of the fittest in modern interventional cardiology.

Bhatia VK, Di Mario C.

Heart. 2006 Aug;92(8):1017-8. Epub 2006 Jan 31.

Items per page

Supplemental Content

Write to the Help Desk